Related Experiment Videos
[Neonatal muscular spinal atrophy: a case report]
P Pavone1, M Velardita, T Trigilia
1Dipartimento di Pediatria,Azienda Gravina, Caltagirone (CT).
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|February 11, 2005
Summary
Spinal Muscular Atrophy (SMA) is a genetic disorder causing muscle weakness. This case highlights an uncommon early-onset SMA with significant respiratory issues, diagnosed via genetic testing for the SMN gene mutation.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Spinal Muscular Atrophy (SMA) is an autosomal recessive neuromuscular disorder.
- It is caused by deletions in the survival motor neuron (SMN) gene on chromosome 5q13.
- Pathological findings include a reduction in spinal cord motorneurons.
Observation:
- SMA is clinically classified into types 0, 1, 2, and 3 based on age of onset and severity.
- Type 1 (Werdnig-Hoffmann) presents within 6 months, leading to death by age two.
- Type 2 involves later onset, ability to sit, while Type 3 allows walking with mild weakness.
- Type 0, a severe neonatal form, features facial weakness and rapid progression.
Findings:
- This report details an unusual case of SMA with early onset and pronounced respiratory difficulties.
- Genetic analysis confirmed a mutation in the SMN gene, leading to the diagnosis.
Implications:
- Early and accurate diagnosis of SMA is crucial for timely intervention.
- Understanding genetic mutations aids in diagnosing rare presentations of SMA.
- Further research into SMA pathogenesis and treatment is warranted.